PaÃno, T.; González-Méndez, L.; San-Segundo, L.; Corchete, L.A.; Hernández-GarcÃa, S.; DÃaz-Tejedor, A.; AlgarÃn, E.M.; Mogollón, P.; MartÃn-Sánchez, M.; Gutiérrez, N.C.;
et al. Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma. Cancers 2020, 12, 2743.
https://doi.org/10.3390/cancers12102743
AMA Style
PaÃno T, González-Méndez L, San-Segundo L, Corchete LA, Hernández-GarcÃa S, DÃaz-Tejedor A, AlgarÃn EM, Mogollón P, MartÃn-Sánchez M, Gutiérrez NC,
et al. Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma. Cancers. 2020; 12(10):2743.
https://doi.org/10.3390/cancers12102743
Chicago/Turabian Style
PaÃno, Teresa, Lorena González-Méndez, Laura San-Segundo, Luis A. Corchete, Susana Hernández-GarcÃa, Andrea DÃaz-Tejedor, Esperanza M. AlgarÃn, Pedro Mogollón, Montserrat MartÃn-Sánchez, Norma C. Gutiérrez,
and et al. 2020. "Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma" Cancers 12, no. 10: 2743.
https://doi.org/10.3390/cancers12102743
APA Style
PaÃno, T., González-Méndez, L., San-Segundo, L., Corchete, L. A., Hernández-GarcÃa, S., DÃaz-Tejedor, A., AlgarÃn, E. M., Mogollón, P., MartÃn-Sánchez, M., Gutiérrez, N. C., Mateos, M.-V., Garayoa, M., & Ocio, E. M.
(2020). Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma. Cancers, 12(10), 2743.
https://doi.org/10.3390/cancers12102743
